References
- Pizzo P A. Management of fever in patients with cancer and treatment-induced neutropenia. N Engl J Med 1993; 328: 1323–1332
- Bodey G P, Buckley M, Sathe Y S, et al. Quantitative relationship between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 1996; 64: 328–340
- Esparza L, Yap H Y, Smith T, et al. Quantitative relationship between degree of myelosuppression and infection in patients with metastatic breast cancer (MBC). Proc Am Soc Clin Oncol 1983; 2: 89, (abstract C-348)
- ASCO Ad Hoc Colony-Stimulating Factor Guideline Expert Panel: American Society of Clinical Oncology recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. J Clin Oncol 1994; 12: 2471–2508
- ASCO Health Services Research Committee and CSF Review Committee: Update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. J Clin Oncol 1996; 14: 1957–1960
- Hartmann L C, Tschetter L K, Habermann T M, et al. G-CSF versus placebo for afebrile neutropenic patients. Proc Am Soc Clin Oncol 1996; 15: 272, (abstract)
- Maher D W, Lieschke G J, Green M, et al. Filgrastim in patients with chemotherapy-induced febrile neutropenia: a double-blind, placebo-controlled trial. Ann Intern Med 1994; 121: 492–501
- Mayodormo J I, Rivera F, Diaz-Puente M T, et al. Decreasing morbidity and cost of treating febrile neutropenia by adding G-CSF and GM-CSF to standard antibiotic therapy: results of randomized trial. Proc Am Soc Clin Oncol 1993; 12: 437, (abstract)
- Amgen Inc: Neupogen® (filgrastim) filgrastim prescribing information. Thousand Oaks, CA Dec, 1994
- Kellihan M J. Drug formulary review process for sargramostim and filgrastim: focus on analysis of adverse drug reactions. Clin Ther 1993; 15: 927–937
- Beveridge R A, Kales A N, Binder R A, et al. Comparison of toxicities of G-CSF and yeast-derived GM-CSF. Blood 1993; 82(suppl l)495a, (abstract)
- Beveridge R A, Miller J A. Impact of colony-stimulating factors on the practice of oncology. Oncology 1993; 7(12 suppl)43–48